• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations

ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations

by Truveta Research | May 30, 2025 | Research, Research Insights

Authors: Patricia J. Rodriguez, PhD, MPH ⊕Truveta, Inc, Bellevue, WA Duy Do, PhD ⊕Truveta, Inc, Bellevue, WA, Brianna M. Goodwin Cartwright, MS ⊕Truveta, Inc, Bellevue, WA, Jennifer Liang, MD ⊕Truveta, Inc, Bellevue, WA, Keenan Robbins, MBBS ⊕Washington University...
Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers

Truveta leads a new era in cancer research with the most complete, representative, and timely real-world data on all cancers

by Truveta staff | May 8, 2025 | News

With more than 7 million oncology patient journeys spanning more than 100 cancer types, Truveta is leading a new era in cancer research, delivering an unprecedented breadth of regulatory grade data to support researchers in accelerating oncology therapy adoption and...
Truveta Data used in new study exploring trends in colorectal cancer screening

Truveta Data used in new study exploring trends in colorectal cancer screening

by Truveta staff | Nov 4, 2024 | Research

Citation: Shaukat, Aasma MD, MPH et al. Real-World Adherence to Repeat Testing for Stool-Based Non-Invasive Colorectal Cancer Screening Tests Among Individuals With Average Risk. The American Journal of Gastroenterology 119(10S):p S265-S266, October...

Share this


Recent posts

  • ASCO 2025: Development and validation of machine learning risk prediction models for detection of early-onset colorectal cancer
  • ASCO 2025: Changes in colorectal cancer screening and detection following USPSTF expanded recommendations
  • Prostate cancer is in the headlines — and early detection has never been more important

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice